By activating glucagon-like peptide-1 (GLP-1) receptors, retatrutide stimulates insulin secretion from pancreatic beta cells and inhibits glucagon release
Effects of liraglutide on glucose and lipid metabolism and insulin resistance in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease
Its main functions include stimulating insulin secretion, reducing glucagon levels, slowing gastric emptying, and promoting satiety
Its physiological actions include stimulating glucose-dependent insulin secretion from pancreatic beta cells, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways
Sun L, Su Y, Jiao A, Wang X, Zhang B
Quick Answer: Most long-acting GLP-1 injections can be taken with or without food, as stomach contents do not affect their subcutaneous absorption or efficacy